Thursday 2 December, 2021

Taking Cancer On Podcast – Episode 4

Boehringer Ingelheim’s podcast called Taking Cancer On has just released its fourth episode. Hosted by Sebastian Hermelin, co-founder of War On Cancer, this new episode covers cancer immunology, discussing how the immune system can be used to treat cancer and the future of immunotherapies.

Episode 4: Helping the Immune System to Take Cancer On

Expert Guests: In this episode, we hear from Jose Barrueco Ph.D. and Petra Blum M.D., both leading Global Clinical Development teams in Oncology at Boehringer Ingelheim (BI).

In this episode, Jose and Petra discuss cancer immunology and explain what it takes to develop cancer immunotherapies. How can the immune system be used to treat cancer? What is the future of cancer immunotherapy and what is Boehringer Ingelheim contributing to this field? Jose and Petra share their perspectives on cancer immunology and immunotherapies, the difference between the two, the work being done now and what future of this field.

Take a listen to episode 4 here.

About Taking Cancer On – The Podcast

In an effort to simplify the science behind Boehringer Ingelheim’s ambition to ‘drug the undruggable’, this podcast draws back the curtain on cancer research and takes a look at its complex inner workings.  Hosted by Sebastian Hermelin (co-founder of the War On Cancer app), each episode welcomes a new expert guest who takes the listener through one of the many stages of cancer research and drug development; from early discovery efforts, through to clinical trials and drug approval.

If you haven’t already, make sure to listen to episode 3 about the power of research partnerships in progressing cancer innovation and drug development from Dr Scott DeWire, Head of US Business Development at Boehringer Ingelheim (BI) and Dr. Andrew Fadden, Head of Corporate Development at Enara Bio.

Or, listen to the War On Cancer podcast episode about how Health Studies in the War On Cancer app is progressing cancer research and care forward by making it patient-centric.

Keep Reading

Get the latest War On Cancer articles

Share your story today, it will make a difference.